(Q35550777)

8 August 2017

1 reference

title

Translating monotherapy trials into clinical practice: a look into the abyss (English)

1 reference

8 August 2017

2

Emilio Perucca

1 reference

8 August 2017

Santiago Arroyo

1

1 reference

8 August 2017

language of work or name

1 reference

1 October 2003

1 reference

8 August 2017

1 reference

8 August 2017

volume

4

1 reference

8 August 2017

issue

5

1 reference

8 August 2017

page(s)

457-463

1 reference

Early identification of refractory epilepsy

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.07.011

Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.07.011

Limitations of monotherapy trials in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.07.011

A workshop on antiepileptic drug monotherapy indications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.07.011

Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 1200 mg/day) in a Q.I.D. regimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.07.011

Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.07.011

Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.07.011

A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.07.011

Clinical pharmacology and therapeutic use of the new antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.07.011

Hazards of inference: the active control investigation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.07.011

Adjunctive clinical trials in epilepsy: is a placebo arm necessary?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.07.011

Innovative monotherapy trial designs for the assessment of antiepileptic drugs: a critical appraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.07.011

Monotherapy trials with the new antiepileptic drugs: study designs, practical relevance and ethical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.07.011

Conversion to monotherapy: clinical trials in patients with refractory partial seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.07.011

The Ethical and Scientific Shortcomings of Current Monotherapy Epilepsy Trials in Newly Diagnosed Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.07.011

Active-Control Antiepileptic Drug Trials in the Newly Diagnosed Patient: Are We Getting Closer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.07.011

An active-control trial of lamotrigine monotherapy for partial seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.07.011

Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.07.011

Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.07.011

Active-Control Comparative Equivalency Monotherapy Trials in Epilepsy: Are They Scientifically Valid?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.07.011

Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.07.011

Carbamazepine in comparative trials: pharmacokinetic characteristics too often forgotten

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.07.011

10.1016/J.YEBEH.2003.07.011

7 January 2021

Identifiers

DOI

1 reference

8 August 2017

1 reference